1. Cunha CB, Prolonged and perplexing fevers in antiquity: malaria and typhoid Fever. Infect Dis Clin North Am 2007;21:857-866.
2. Cunha BA. Fever of Unknown Origin: clinical overview and perspective. In: Cunha BA (Editor) Fever of Unknown Origin. Informa Healthcare New York 2007:pp.1-8.
3. Petersdorf RG, Beeson PB. Fever of Unexplained Origin: Report on 100 cases. Medicin 1961;40:1-30.
4. Durack D, Street A. Fever of unknown origin: reexamined and redefined. Curr Clin Top Infect Dis 1991;11:35-51.
5. Larson EB, Featherstone HJ, Petersdorf RG. Fever of undetermined origin: diagnosis and follow-up of 105 cases, 1970-80. Medicine 1982;61:269-292.
6. Molavi A, Weinstein L. Persistent perplexing pyrexia. Some comments on etiology and diagnosis. Med Clin North Am 1970;54:379-396.
7. Louria DB. Fever of unknown etiology. Del Med J 1971;43:343-348.
8. Jacoby GA, Swartz MN. Fever of undetermined origin. N Engl J Med 1973;289:1407-1410. 9. Tumulty PA, (Editor). The Patient with Fever of Unknown Origin: The Effective Clinician. Philadelphia: WB Saunders, 1973;pp.137-170.
10. Cunha BA. Fever of unknown origin. Infect Dis Clin North Am 1996;10:111-128.
11. Lortholary O, Bletry LG, Godeau P. Fever of unknown origin: a retrospective multicentre study of 103 cases, 1980 – 88. Eur J Med 1992;3:109-120.
12. Brusch JL, Weinstein L. Fever of unknown origin. Med Clin North Am 1988;72:1247-1261. 13. Knockaert DC, Vanderschueren S, Blockmans D. Fever of unknown origin in Adults: 40 years on. J Intern Med 2003;263-275.
14. Bryan CS. Fever of unknown origin. Arch Intern Med 2003;163:1003-1004.
15. Arnow PM, Flaherty JP. Fever of unknown origin. Lancet. 1997;350:575-580.
16. Nubile MJ. Acute fevers of unknown origin. A plea for restraint. Arch Intern Med 1993;153:2525-2526.
17. Vanderschueren S, Knockaert D, Adriaenssens T, et al. From prolonged febrile illness to fever of unknown origin: The Challenge Continues. Arch Intern Med 2003;163:1033-1041. 18. Ergonul O, Wilke A, Azap A, et al. Revised definition of fever of unknown origin: Limitations and opportunities.treated in community hospital. Clin Infect Dis 1992;15:968-973.
22. Wang C, Armstrong D. Neoplastic Diseases. In: Murray HW, (Editor). Fever of Unknown Origin of Undetermined Origin. Mount Kisco; Futura Publishing, 1983; pp. 39-48.
23. Cunha BA. Fever of unknown origin in malignancies. In: Cunha BA, (Editor). Fever of Unknown Origin. New York, Informa Healthcare, 2007;pp.27-34.
24. Zhang J, Chen B, Xu X, Lin Z, Huang B, Song J, et al. Clinical features of 66 lymphoma patients presenting with a fever of unknown origin. Intern Med. 2012;51:2529-2536.
25. Cunha BA. Fever of Unknown Origin: focused diagnostic approach based on clinical clues from the history, physical examination and laboratory tests. Infect Dis Clin North Am 2007;21:1137-1188.
26. Manfredi R, Calza L, Chiodo F. Primary cytomegalovirus infection in otherwise healthy adults with fever of unknown origin: a 3-year prospective survey. Infection 2006;34:87-90.
27. Cunha BA. Fever of unknown origin. In: Gorbach SL, Bartlett JG, Blacklow NE, (Editors). Infectious Diseases. (3rd Ed) Philadelphia: Lippincott Williams & Wilkins 2005;1568-1577.
28. Carsons SE. Fever in rheumatic and autoimmune disease. Infect Dis Clin North Am 1996;10:67-84.
29. Zenone T. Fever of Unknown Origin in rheumatic diseases. Infect Dis Clin North Am 2007;21:1115-1136.
30. Cunha BA. Fever of unknown origin in rheumatic diseases. In: Cunha BA, Editor. Fever of Unknown Origin. New York, Informa Healthcare 2007;pp.59-64.
31. Cunha BA, Parchuri S, Mohan S. Fever of unknown origin: temporal arteritis presenting with persistent cough and elevated serum ferritin levels. Heart & Lung 2006;35:112-116.
32. Cunha BA, Nausheen S. Fever of unknown origin due to cyclic neutropenia with relative bradycardia. Heart & Lung 2009;38:350-353.
33. Cunha BA, Mickail N, Durie N, Pherez FM, Strollo S. Fever of unknown origin caused by Kikuchi’s disease mimicking lymphoma. Heart & Lung 2009;38:450-456.
34. Cunha BA, Durie N, Selbs E, Pherez F. Fever of unknown origin due to Rosai-Dorfman disease with mediastinal adenopathy mimicking lymphoma: diagnostic importance of elevated serum ferritin levels and polyclonal gammopathy. Heart & Lung 2009;38:83-88.
35. Brendan MW, Matthew JH, Dennis PM. Subacute thyroiditis manifesting as fever of unknown
origin. South Med J 2000;93:926-929.
36. Cunha BA, Thermidor M, Mohan S, et al. Fever of unknown origin: subacute thyroiditis versus typhoid fever. Heart & Lung 2005;34:147-151.
37. Cunha BA, Chak A, Strollo S. Fever of unknown origin: de Quervain’s subacute thyroiditis with highly elevated ferritin levels mimicking temporal arteritis (TA). Heart & Lung 2010;39:73-77.
38. Cunha BA, Berbari N. Subacute thyroiditis (de Quervain’s) due to influenza A: presenting asfever of unknown origin. Heart & Lung 2013;42:77-78.
39. Murray HW. Factitious fever updated. Arch Intern Med 1979;139:739-740.
40. Johnson DH, Cunha BA. Drug fever. Infect Dis Clin North Am 1996;10:85-92.
41. Drenth JPH, Haagsma CJ, van der Meer JWM, and the International Hyper-IgD study group. Hyperimmunoglobulinemia D and periodic fever syndrome.The clinical spectrum in a series of 50 patients. Medicine 1994;73:133-144.
42. Wolf SM, Fauci AS, Dale DC. Unusual etiologies of fever and their evaluation. Annual Rev Med 1975;26:277-281.
43. Norman DC, Wong MB. Fever of unknown origin in older persons. In: Cunha BA (Editor) Fever of Unknown Origin. New York: Informa Healthcare 2007;pp.109-114.
44. Cunha BA. Diagnostic significance of relative bradycardia. Clin Microbiol Infect 2000;6:633-634.
45. Cunha CB. Infectious disease differential diagnosis. In: Cunha BA (Editor). Antibiotic Essentials (12th Ed) Sudbury MA, Jones & Bartlett. 2013;pp. 472-504.
46. Cunha CB, Wilkinson MJ, Quillen DA. Ophthalmologic clues to infectious diseases. In Cunha BA, (Editor). Infectious Diseases in Critical Care Medicine (3rd Ed.) New York, Informa
2010;pp. 66-75.
47. Cunha BA. The mimics of endocarditis. In: Brusch JL, (Editor). Infective Endocarditis: Management in the Era of Intravascular Devices. New York: Informa Healthcare, 2006; pp.345-354.
48. Esposito AL, Gleckman RA. A diagnostic approach to the adult with fever of unknown origin. Arch Intern Med 1979;139:575-578.
49. Esposito AL. Planning and proceeding with the diagnostic evaluation. In: Murray HW (Editor) Fever of Undetermined Origin. Mount Kisco: Futura Publishing 1983;pp.141-145.
50. Cunha BA. Fever of unknown origin: a focused diagnostic approach. In: Cunha BA (Editor) Fever of Unknown Origin. New York Informa Healthccare 2007;pp.9-16.
51. Cunha BA. The diagnostic significance of fever curves. Infect Dis Clin North Am 1996;10:33-44.
52. Cunha BA, Krakakis J, McDermott BP. Fever of unknown origin caused by military tuberculosis: diagnostic significance of morning temperature spikes. Heart & Lung 2009; 38:77-82.
53. Cunha BA. Fever of unknown origin caused by adult juvenile rheumatoid arthritis: the diagnostic significance of double quotidian fevers and elevated serum ferritin levels. Heart & Lung 2004:33:417-421.
54. Cunha BA, Hage JE, Nouri Y. Recurrent fever of unknown origin : aseptic meningitis, hepatosplenomegaly, pericarditis and a double quotidian fever due to juvenile rheumatoid arthritis (JRA). Heart & Lung 2012;41:177-180.
55. Cunha BA. Nonspecific tests in the diagnosis of fever of unknown origin. In: Cunha BA, (Editor). Fever of unknown origin. New York Informa Healthcare 2007; pp.151-158.
56. Purnendu S, Louria DB. Non-invasive and invasive diagnostic procedures and laboratory methods. In: Henry W Murray (Editor). Fever of Unknown Origin Fever of undetermined origin. Mount Kisco: Futura Publishing; 1983; pp.159-190.
57. Cunha BA, Petelin A. Fever of unknown origin due to large B-cell lymphoma: the diagnostic significance of highly elevated alkaline phosphatase and serum ferritin levels. Heart & Lung 2013;42:67-71.
58. Cunha BA. Fever of unknown origin : diagnostic importance of serum ferritin levels. Scan J Infect Dis 2007;39:651-652.
59. Kosmin A, Lorber B. Specific tests in the diagnosis of fever of unknown origin. In: Cunha BA (Editor) Fever of Unknown Origin. New York, Informa Healthcare 2007;159-208.
60. Chang JC, Gross HM. Utility of naproxen in the differential diagnosis of fever of undetermined origin in patients with cancer. Am J Med 1984;76:597-603.
61. Cunha BA, Bouyarden M, Hamid N. Multiple myeloma presenting as a fever of unknown Origin: The diagnostic importance of the naprosyn test. Heart & Lung 2006;35:358-362.
62. Trivedi Y, Yung E, Katz DS. Imaging in fever of unknown origin. In: Cunha BA, (Editor). Fever of unknown origin. New York Informa Healthcare 2007;pp.209-228.
63. Pedersen TI, Roed C, Knudsen LS, Loft A, Skinhoj P, Nielsen SD. Fever of unknown origin: a retrospective study of 52 cases with evaluation of the diagnostic utility of FDG-PET/CT. Scand J Infect Dis 2012;44:18-23.
64. Ben-Baruch S, Canaani J, Braunstein R, et al. Predictive parameters for a diagnostic bone marrow biopsy specimen in the work-up of fever of unknown origin. Mayo Clin Proc 2012;87:136-142.
65. Jha A, Sarda R, Gupta A, Talwar OP. Bone marrow culture vs blood culture in Fever of Unknown Origin. J Nepal Med Assoc 2009;48:135-138.
66. DeKleijn EM, van Lier HJ, van der Meer JW. Fever of unknown origin (. II. Diagnostic procedures in a prospective multicenter study of 167 patients. The Netherlands Fever of Unknown Origin Study Group. Medicine 1997;76:401-414.
67. Zenone T. Fever of unknown origin in adults: evaluation of 144 cases in a non-university hospital. Scand J Infect Dis 2006;38:625-631.
68. Mayo J, Collazos J, Martinez E. Fever of unknown origin in the HIV-infected patient: new scenario for an old problem. Scand J Infect Dis. 1997;29:327-336.
69. Armstrong WS, Katz JT, Kazanjian PH. Human immunodeficiency virus-associated fever of unknown origin: a study of 70 patients in the United States and review. Clin Infect Dis. 1999;28:341-345.
70. Hot A, Schmulewitz L, Viard JP, Lortholary O. Fever of unknown origin in HIV/AIDS patients. Infect Dis Clin N Am 2007; 21:1013-1032.
71. Miralles P, Moreno S, Perez-Tascon M, Cosin J, Diaz MD, Bouza E. Fever of uncertain origin in patients infected with the human immunodeficiency virus. Clin Infect Dis. 1995;20:872-875.
72. Lozano F, Torre-Cisneros J, Santos J, et al. Impact of highly active antiretroviral therapy on
fever of unknown origin in HIV-infected patients. Eur J Clin Microbiol Infect Dis. 2002;21:137-139.
73. Havlir DV, Barnes PF. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med. 1999;340:367-373.
74. Park BJ et al. Estimation of the current global burden of cryptococcal meningitis among personsliving with HIV/AIDS. AIDS 2009;23: 525-30.
75. Micol R et al. Prevalence, risk factors, and impact on outcome of cytomegalovirus replication in serum of Cambodian HIV-infected patients (2004-2007). J Acquir Immune Defic Syndr 2009;51: 486-491.
76. Nokta MA, Holland F, De Gruttola V, et al. Cytomegalovirus polymerase chain reaction profiles in individuals with advanced human immunodeficiency virus infection: relationship to cytomegalovirus disease. J Infect Dis. 2002;185:1717-1722.
77. Deayton JR, Prof Sabin CA, Johnson MA, Emery VC, Wilson P, Griffiths PD. Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy. Lancet. 2004;363:2116-2121.
78. Peigne V et al. Imported acquired immunodeficiency syndrome-related histoplasmosis in metropolitan France: a comparison of pre-highly active anti-retroviral therapy and highly active anti-retroviral therapy eras. Am J Trop Med Hyg 2011; 85: 934-41.
79. Wheat LJ, Connolly-Stringfield PA, Baker RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore). 1990;69:361-374.
80. Woods CW, McRill C, Plikaytis BD, et al. Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994-1997: incidence, risk factors, and prevention. J Infect Dis. 2000;181:1428-1434.
81. Fish DG, Ampel NM, Galgiani JN, et al. Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients. Medicine (Baltimore). 1990;69:384-391.
82. Wong SS, Wong KH, Hui WT, et al. Differences in clinical and laboratory diagnostic characteristics of penicilliosis marneffei in human immunodeficiency virus (HIV)- and non-HIV-infected patients. J Clin Microbiol. 2001;39:4535-4540.
83. Jarvis JN, Lockwood DN. Clinical aspects of visceral leishmaniasis in HIV infection. Curr Opin Infect Dis 2013; 26: 1-9.
84. Zylberberg H, Robert F, Le Gal FA, Dupouy-Camet J, Zylberberg L, Viard JP. Prolonged isolated fever due to attenuated extracerebral toxoplasmosis in patients infected with human immunodeficiency virus who are receiving trimethoprim-sulfamethoxazole as prophylaxis. Clin Infect Dis. 1995;21:680-681.
85. Koehler JE, Sanchez MA, Tye S, et al. Prevalence of Bartonella infection among human immunodeficiency virus-infected patients with fever. Clin Infect Dis. 2003;37:559-566.
86. Lortholary O, Meyohas MC, Dupont B, et al. Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS. Am J Med. 1993;95:177-187.
87. Goedert JJ, Cote TR, Virgo P, et al. Spectrum of AIDS-associated malignant disorders. Lancet. 1998;351:1833-1839.
88. Cribb AE, Lee BL, Trepanier LA, Spielberg SP. Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: clinical syndromes and pathogenesis. Adverse Drug React Toxicol Rev. 1996;15:9-50.
89. Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet. 2000;356:1423-1430
90. Fellay J, Boubaker K, Ledergerber B, et al. Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet. 2001;358:1322-1327.
91. Shelburne SA, Visnegarwala F, Darcourt J, et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS. 2005;19:399-406.
92. Bouza E, Loeches B, Munoz P. Fever of Unknown Origin in Solid Organ Transplant Recipients. In: Cunha BA (Editor) Fever of Unknown Origin. Informa Healthcare New York 2007:79-100.
93. Bonham CA, Dominguez EA, Fukui MB, et al. Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management. Transplantation 1998;66:1596-1604.
94. Ionescu DN, Dacic S. Persistent fever in a lung transplant patient. Arch Pathol Lab Med 2005;129:e153-154.
95. Wulf MW, van Crevel R, Portier R, et al. Toxoplasmosis after renal transplantation: implications of a missed diagnosis. J Clin Microbiol 2005;43:3522-3547.
96. Maegraith B. Unde venis? Lancet 1963;1:401-403.
97. Saxe SE, Gardner P. The returning traveler with fever. Infect Dis Clin North Am 1992;6:427-439.
98. Speil C, Mushtaq A, Adamski A, Khardori N. Fever of Unknown Origin in the Returning Traveler. Infect Dis Clin North Am. 2007:1091-1114.
99. Cleri DJ, Ricketti AJ, Vernaleo JR. Fever of Unknown Origin Due to Zoonoses. Infect Dis Clin North Am. 2007;21:963-996.
100. Botelho-Nevers E, Raoult D. Fever of Unknown Origin due to rickettsioses. Infect Dis Clin North Am. 2007;21:997-1011.
101. O’Brien D, Tobin S, Brown GV, et al. Fever in returned travelers: review of hospital admissions for a 3-year period. Clin Infect Dis 2001;5:603-609.
102. Lortholary O, Charlier C, Lebeaux D, Lecuit M, Consigny PH. Fungal infections in immunocompromised travelers. Clin Infect Dis 2013; 56: 861-9.
103. Knockaert DC, Durjardin KS, Bobbaers HJ. Long-term follow-up of patients with undiagnosed fever of unknown origin. Arch Intern Med 1996;156:618-620.
104. Collazos, J, Guerra E, Mayo J, et al. Tuberculosis as a cause of recurrent fever of unknown origin. J Infect 2000;41:269-272.
105. Lekstrom-Himes JA, Dale JK, Kingma DW, et al. Periodic illness associated with Epstein-Barr virus infection. Clin Infect Dis 1996;22:22-27.
106. Munoz-Gomez S, Cunha BA. Recurrent Fever of Unknown Origin in an adult due to FAPA syndrome. J Clin Med 2013;2:45-48.
107. Weinstein L. Clinically benign fever of Unknown Origin: A personal retrospective. Rev Infect Dis 1985;7:692-699.
108. Knockaert, DC. Recurrent Fevers of Unknown Origin. Infect Dis Clin North Am 2007;21:1189-1211.
109. Bryan CS, Ahuja D. Fever of Unknown Origin: Is there a role for empiric therapy. Infect Dis Clin North Am. 2007;21:1213-1220.
110. Eiko LM, Bryan CS. Empiric therapy in Fever of Unknown Origin: a cautionary note. In: Cunha BA (Editor) Fever of Unknown Origin. New York. Informa Healthcare. 2007:pp.229-236.
Comentarios
Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.